These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1835742)

  • 61. Proton pump inhibitors: how appropriate?
    Sadowski DC
    Can J Gastroenterol; 2000 Sep; 14(8):667. PubMed ID: 11185529
    [No Abstract]   [Full Text] [Related]  

  • 62. [Treatment of H2-blocker-resistant reflux esophagitis in severely handicapped children with omeprazole].
    Maeoka Y; Eda I
    No To Hattatsu; 1996 Jan; 28(1):74-7. PubMed ID: 8579863
    [No Abstract]   [Full Text] [Related]  

  • 63. Omeprazole, the first proton pump inhibitor for peptic ulcer disease. Proceedings of the symposium held during the 8th Asian Pacific Congress of Gastroenterology. Seoul, Korea, 11 October 1988.
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():1-81. PubMed ID: 2491357
    [No Abstract]   [Full Text] [Related]  

  • 64. [The treatment for reflux esophagitis which is refractory to proton pump inhibitor therapy].
    Adachi K
    Nihon Shokakibyo Gakkai Zasshi; 2006 Nov; 103(11):1233-7. PubMed ID: 17085903
    [No Abstract]   [Full Text] [Related]  

  • 65. Combined therapies for upper gastrointestinal disorders--any advantage?
    Guslandi M
    Lancet; 1988 Jun; 1(8599):1383-5. PubMed ID: 2898054
    [No Abstract]   [Full Text] [Related]  

  • 66. Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
    Campo N; Alvarez S; Borzone S; Caglieris S; Zentilin P; Testa R
    Am J Gastroenterol; 1994 Aug; 89(8):1271-2. PubMed ID: 8053457
    [No Abstract]   [Full Text] [Related]  

  • 67. Conventional dose of omeprazole alters gastric flora.
    Karmeli Y; Stalnikowitz R; Eliakim R; Rahav G
    Dig Dis Sci; 1995 Sep; 40(9):2070-3. PubMed ID: 7555466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of mouse skin carcinoma in the rapid growing stage.
    Ohkoshi M; Fujii S
    J Dermatol; 1984 Feb; 11(1):21-4. PubMed ID: 6376571
    [No Abstract]   [Full Text] [Related]  

  • 69. A proteinase inhibitor reduces proteinuria in nephrotic syndrome.
    Makino H; Onbe T; Kumagai I; Murakami K; Ota Z
    Am J Nephrol; 1991; 11(2):164-5. PubMed ID: 1951480
    [No Abstract]   [Full Text] [Related]  

  • 70. [A double-blind short-term clinical trial of furazolidone on peptic ulcer].
    Zheng ZT
    Zhonghua Nei Ke Za Zhi; 1984 Apr; 23(4):195-7. PubMed ID: 6386383
    [No Abstract]   [Full Text] [Related]  

  • 71. Therapeutic achlorhydria and risk of gastric cancer.
    Wormsley KG
    Gastroenterol Jpn; 1989 Oct; 24(5):585-96. PubMed ID: 2680746
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical experience with a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate for prevention of recurrence of carcinoma of the mouth and in treatment of terminal carcinoma.
    Ohkoshi M; Oka T
    J Maxillofac Surg; 1984 Aug; 12(4):148-52. PubMed ID: 6590712
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Personal experience in TCM treatment of reflux esophagitis.
    Hong L
    J Tradit Chin Med; 2003 Sep; 23(3):175-6. PubMed ID: 14535176
    [No Abstract]   [Full Text] [Related]  

  • 74. Omeprazole: blocks gastric acid secretion completely.
    Drug Ther Bull; 1990 Jun; 28(13):49-52. PubMed ID: 2131211
    [No Abstract]   [Full Text] [Related]  

  • 75. Controversies, dilemmas, and dialogues. Reduction of gastric acidity in the treatment of peptic ulcer disease: how low should we go?
    Peterson WL; Harford WV
    Am J Gastroenterol; 1991 Jun; 86(6):671-5. PubMed ID: 1674838
    [No Abstract]   [Full Text] [Related]  

  • 76. [The present state of knowledge on the treatment of peptic diseases with cimetidine].
    Romankiewicz JA; Reidenberg MM
    Internist (Berl); 1981 Dec; 22(12):762-6. PubMed ID: 6797984
    [No Abstract]   [Full Text] [Related]  

  • 77. [Treatment of peptic ulcer and reflux esophagitis with enzyme inhibitors].
    Moriya S; Omura N; Kashiwagi H; Inagaki Y; Aoki T
    Nihon Rinsho; 1991 Sep; 49(9):2115-9. PubMed ID: 1835742
    [No Abstract]   [Full Text] [Related]  

  • 78. [Omeprazole. A new substance for inhibiting acid production].
    Uhl D
    Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.